Claude James
Rhône-Poulenc
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Claude James.
Biochemical Pharmacology | 1987
Christine Robaut; Gabrielle Durand; Claude James; Daniel Lave; Pierre Sedivy; Anne Floch; Serge Mondot; Daniel Pacot; Icilio Cavero; Gérard Le Fur
52770 RP, the N-(3-chlorophenyl)-3-(3-pyridinyl)-1H,3H-pyrrolo[1,2-c]thiazole -7-carboxamide, displaces in a potent, specific and competitive manner [3H]PAF from its binding sites on rabbit platelets. Since 52770 RP is not structurally related to PAF and has low liposolubility with respect to PAF, it was selected as a potential radioligand for PAF receptor sites. [3H]52770 RP displayed high-affinity, specificity, as well as saturable and displaceable binding to a single class of recognition sites in intact platelets and crude platelet membranes. In these preparations, the values of binding parameters were, respectively, 8.5 and 7.6 nM for Kd, 0.2 pmol/5 X 10(7) platelets and 3.66 pmol/mg protein for Bmax and 0.96 and 0.91 for nH. Inasmuch as the (+)-52770 RP was 300-fold more potent than the (-)-isomer at displacing [3H]52770 RP in intact platelets, the studied binding site manifested stereospecific discrimination. A variety of pharmacological agents including pro- and anti-aggregant compounds did not exhibit affinity for [3H]52770 RP binding sites. In contrast, PAF, some of its active analogues and several recognized PAF antagonists (BN 52021, brotizolam, L-652,731, triazolam), displaced the [3H]52770 RP binding. Studies carried out using [3H]PAF demonstrated that 52770 RP was approximately 4- and 200-fold more potent than L-652,731 and BN 52021 respectively, as a PAF-receptor antagonist. In washed rabbit platelets, the rank order of potency (Ki) for several analogues of 52770 RP, to displace [3H]PAF from its binding sites, was highly correlated (r = 0.96) to their ability to antagonize [3H]52770 RP binding. In functional studies, 52770 RP antagonized not only the PAF-induced aggregation in washed rabbit platelets but also the hypotension evoked by PAF in the anesthetized rat. In this respect, it was 26 and 2 times more potent than L-652,731, respectively. In conclusion, [3H]52770 RP might represent a novel interesting tool for furthering our understanding of the role of PAF binding sites in pathophysiological processes.
Tetrahedron Letters | 1985
Jean-Louis Fabre; Daniel Farge; Claude James; Daniel Lave
Abstract The 1,3-dipolar cycloaddition of 2-chloroacrylonitrile on N-(2-pyridinecarbonyl) proline 1a and thio analogue 1b affords unexpected bridged compounds 2 and 3, the reactivity of which versus H2S is described.
Journal of The Chemical Society-perkin Transactions 1 | 1989
Jean Bouchaudon; Gilles Dutruc-Rosset; Daniel Farge; Claude James
RP 56142, a new immunoactive peptide was synthesized on large scale (ca. 500 g)viaL-2,6-diaminopimelic acid which was prepared by chemical or biochemical synthesis. The key derivative, N6-benzyloxycarbonyl-L-2,6-diaminopimelamic acid was synthesized by two methods. In the first, we used a copper chelate procedure. In the second, we selectively deblocked the amine at the α-position to the free carboxylic group by the N-carboxyanhydride method. Condensation of N6-benzyloxycarbonyl-L-2,6-diaminopimelamic acid and the appropriately protected lauroyl dipeptide and removal of the protecting groups afforded RP 56142.
Journal of Medicinal Chemistry | 1996
Michel Evers; Christèle Poujade; Francoise Soler; Yves Ribeill; Claude James; Yves Lelièvre; Jean-Christophe Gueguen; Daniel Reisdorf; Isabelle Morize; Rudi Pauwels; Erik De Clercq; Yvette Henin; Anne Bousseau; Jean-Francois Mayaux; and Jean-Bernard Le Pecq; Norbert Dereu
Archive | 1994
Romaine Bouboutou; Norbert Dereu; Michel Evers; Jean-Christophe Gueguen; Claude James; Christèle Poujade; Daniel Reisdorf; Yves Ribeill; Francoise Soler
Journal of Medicinal Chemistry | 1987
Jean-Claude Aloup; Jean Bouchaudon; Daniel Farge; Claude James; Jean Deregnaucourt; Monique Hardy-Houis
Archive | 1989
Francois Audiau; Claude James
Archive | 1991
Francois Audiau; Claude James
Archive | 1987
Jean-Louis Fabre; Claude James; Daniel Lave
Archive | 1984
Jean-Louis Fabre; Daniel Farge; Claude James; Daniel Lave